Balancing Affinity, Selectivity, and Cytotoxicity of Hydrazone-Based G-Quadruplex Ligands for Activation of

Simona Marzano1, Giulia Miglietta2, Rita Morigi2

  • 1Department of Pharmacy, University of Naples Federico II, 80131 Naples, Italy.

Insights

New anticancer drugs targeting G-quadruplex (G4) structures show promise. Ligands with high G4 affinity but low cytotoxicity effectively stimulate immune genes, offering a novel therapeutic strategy.

Area of Science:

  • Oncology
  • Drug Discovery
  • Immunology

Background:

  • G-quadruplex (G4) ligands are explored as anticancer agents.
  • These ligands can induce genome instability and activate innate immune genes.
  • The relationship between G4 ligand properties and their biological effects is not fully understood.

Purpose of the Study:

  • To investigate the molecular basis of immune stimulation by G4 ligands.
  • To define the interplay between G4 affinity, cytotoxicity, and immune gene activation.
  • To establish a new rationale for discovering effective anticancer G4 ligands.

Main Methods:

  • Synthesis and evaluation of closely related hydrazone derivatives.
  • Assessment of G4 ligand affinity and selectivity.
  • Measurement of cytotoxicity, genome instability, and innate immune gene activation.

Main Results:

  • Hydrazone derivatives exhibited varying G4 affinity, cytotoxicity, and immune activation.
  • High G4 ligand affinity is crucial for immune gene activation.
  • High cytotoxicity interferes with immune gene activation.

Conclusions:

  • The balance between G4 stabilization and cytotoxicity determines immune gene activation levels.
  • A strategy focusing on low cytotoxicity and high immune stimulation is proposed for developing novel G4 anticancer ligands.